India dengue vaccine approval

India approves first dengue vaccine for individuals aged 4 to 60 years

Takeda’s two-dose QDENGA vaccine, approved by the Drug Controller General of India, can be administered without prior dengue screening and is designed to protect against all four dengue virus serotypes

CDSCO clears recombinant live attenuated dengue vaccine for ages 4 to 60 years

‘The approval has been granted after a comprehensive scientific evaluation of the vaccine’s quality, safety and efficacy,’ said the Union Health Ministry

India approves its first dengue vaccine Qdenga: How it works, who is eligible, and why it isn't a silver bullet

Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two doses three months apart.

QDENGA: India’s first approved dengue vaccine

QDENGA, India’s first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts.

Health, politics and access

Dengue vaccine approval, protests, healthcare access, climate-linked crises and more

India Develops A New Vaccine To Fight Dengue